Prurigo Nodularis (Chronic Prurigo)

This study is a 12-month, observational, non-interventional study assessing biomarkers, clinical outcomes, and treatment-responsiveness in patients with prurigo nodularis (PN).Patients must be 18 years or older with a confirmed diagnosis of PN (with predominantly nodular disease) by the PI. They must be able to read and understand the consent form and outcomes questionnaires and willing and able to sign the consent form. A separate consent form will be used for genomics testing, which is encouraged for all study participants but not required. Lastly, patients must be willing to participate in the following study-related activities: 1) Completion of outcome questionnaires 2) Actigraphy data collection 3) Biomarker collection by blood draws at each monthly study visit 4) Skin biopsy collection 5) Medical photography (8-24 photos taken each visit)

Primary Sponsor:
Kiniksa Pharmaceuticals

Prinicipal Investigator:
Dr. Adam Friedman

Contact Phone:
202.677.6160

Are you interested in more information on this clinical trial?

First Name *
Last Name *
Email *
Street Address *
City *
State *
Zip Code *
Phone Number 
     
Verification Code *

Please type what you see (all uppercase):